CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities
Net income (loss)	$ (29,581)	$ (44,563)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization, net	88,384	86,874
Asset impairment	1,708	0
Equity in (earnings) loss of unconsolidated ventures	0	577
Amortization of entrance fees	0	(508)
Proceeds from deferred entrance fee revenue	0	324
Deferred income tax (benefit) provision	(425)	244
Operating lease expense adjustment	(13,089)	(10,805)
Change in fair value of derivatives	(3,087)	904
Loss (gain) on sale of assets, net	(704)	0
Non-cash stock-based compensation expense	3,273	3,104
Property and casualty insurance income	(2,626)	(3,295)
Changes in operating assets and liabilities:
Accounts receivable, net	(1,253)	3,143
Prepaid expenses and other assets, net	1,708	(7,602)
Prepaid insurance premiums financed with notes payable	(23,319)	(19,305)
Trade accounts payable and accrued expenses	(25,109)	(1,386)
Refundable fees and deferred revenue	2,725	14,092
Operating lease assets and liabilities for lessor capital expenditure reimbursements	249	2,244
Net cash provided by (used in) operating activities	(1,146)	24,042
Cash Flows from Investing Activities
Purchase of marketable securities	0	(49,674)
Sale and maturities of marketable securities	30,000	30,000
Capital expenditures, net of related payables	(44,399)	(49,700)
Proceeds from sale of assets, net	849	0
Property and casualty insurance proceeds	2,642	6,422
Purchase of interest rate cap instruments	(629)	(212)
Proceeds from interest rate cap instruments	4,659	1,212
Other	(68)	(67)
Net cash provided by (used in) investing activities	(6,946)	(62,019)
Cash Flows from Financing Activities
Proceeds from debt	80,923	25,519
Repayment of debt and financing lease obligations	(20,502)	(23,322)
Payment of financing costs, net of related payables	(2,934)	(346)
Payments of employee taxes for withheld shares	(3,397)	(1,680)
Net cash provided by (used in) financing activities	54,090	171
Net increase (decrease) in cash, cash equivalents, and restricted cash	45,998	(37,806)
Cash, cash equivalents, and restricted cash at beginning of period	349,668	474,548
Cash, cash equivalents, and restricted cash at end of period	$ 395,666	$ 436,742